Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo‐controlled study
Authors:
- 28 December 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (2) , 352-362
Abstract
The efficacy of photodynamic therapy (PDT) with intense pulsed light (IPL) has been shown for treating actinic keratoses (AK) and improving photoaged skin in the face but not yet on the dorsal hands. To evaluate the efficacy of PDT with IPL for treating AK of the dorsal hands, inducing neocollagenesis, and improving photoaged skin. In this prospective, randomized, placebo-controlled, monocentric, within-patient, observer-blinded trial, patients with 1 to 4 mild-to-moderate AK on the dorsal hands were randomly allocated to two different treatment groups: methyl aminolevulinate (MAL) and IPL (λ ≥600nm, 16.2 J/cm², 3 passes, Ellipse Flex PPT) (MAL-IPL) or placebo and IPL (λ ≥600nm, 16.2 J/cm², 3 passes, Ellipse Flex PPT) (placebo-IPL). Patients received three treatments in six-week intervals, and follow-up was 10 weeks after the last treatment. 37 patients aged 68.84±9.28 years were randomized. Primary study endpoints were complete AK clearance per hand and neocollagenesis of subepidermal collagen 10 weeks after the last treatment. Ten weeks after the last treatment, complete AK clearance rates per hand were 54.6% after MAL-IPL and 3.0% after placebo-IPL (p<.0001); complete AK clearance rates per lesion were 69.2% and 14.7% respectively (p<.0001). Thickness of the subepidermal collagen band had increased by 290.6% (±327.4%, p<.001) after MAL-IPL and by 215.5% (±215.3%, p<.001) after placebo-IPL without any significant difference between the two groups. Ratings regarding mottled pigmentation and overall appearance by the blinded investigator were significantly higher for MAL-IPL than for placebo-IPL. Wrinkle size (MAL-IPL: -24.4%, p=.003; placebo-IPL -23.1%, p=.004) and skin roughness (MAL-IPL: -19.6%, p<.001; placebo-IPL: -16.1%, p=.009) were significantly reduced in both groups without any significant difference between the two groups. On the dorsal hands, MAL-IPL reduced AK more efficaciously than placebo-IPL; both treatment modalities significantly improved photoaged skin.Keywords
This publication has 29 references indexed in Scilit:
- Prevalence and risk factors of actinic keratoses in Germany – analysis of multisource dataJournal of the European Academy of Dermatology and Venereology, 2013
- Long‐term (6 and 12 months) follow‐up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF‐200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisBritish Journal of Dermatology, 2012
- Ingenol Mebutate Gel for Actinic KeratosisNew England Journal of Medicine, 2012
- Topical 5-Aminolevulinic Acid with Intense Pulsed Light versus Intense Pulsed Light for Photodamage in Chinese PatientsDermatologic Surgery, 2011
- Comparative split‐face study of 5‐aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skinThe Journal of Dermatology, 2010
- A split‐face study of intense pulsed light on photoaging skin in Chinese populationLasers in Surgery and Medicine, 2010
- Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months dataBritish Journal of Dermatology, 2009
- A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: A randomized, physician-blinded, split-face comparative trialJournal of the American Academy of Dermatology, 2006
- Actinic keratosesJournal of the American Academy of Dermatology, 1997
- A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neckJournal of the American Academy of Dermatology, 1991